首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Journal Of Inflammation-london

Journal Of Inflammation-london杂志,由BioMed Central出版,于2004年创刊,Irregular,出版语言English,ISSN:1476-9255,E-ISSN:1476-9255。

投稿咨询
Journal Of Inflammation-london
Journal Of Inflammation-london
Journal Of Inflammation-london
SCI SCIE

杂志介绍

JCR分区
Q1
中科院分区
2区
影响因子
5.8
CiteScore
6.8
期刊收录
SCI、SCIE

Journal Of Inflammation-london(中文译名:《炎症杂志-伦敦》),ISSN:1476-9255,EISSN:1476-9255,是BioMed Central出版的国际性学术期刊,创刊于2004年,以Irregular形式稳定发行,2026年总发文量约52篇。该刊采用OA开放访问,学科归属为IMMUNOLOGY。该刊是医学、免疫学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达5.8,2025年期刊CiteScore为6.8,2025年期刊自引率约0%,在中科院期刊分区体系中位列医学大类2区,在所属学科领域具备高学术影响力与国际认可度。Journal Of Inflammation-london长期聚焦医学、免疫学及相关产业的技术应用前沿,平均审稿周期>12周,或约稿,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、免疫学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,CHINA MAINLANDUSA、England、Iran、GERMANY (FED REP GER)、Japan、Brazil等为核心发文国家与地区;CHONGQING MEDICAL UNIVERSITYSHANDONG UNIVERSITY、ANHUI MEDICAL UNIVERSITY、FUDAN UNIVERSITY、TABRIZ UNIVERSITY OF MEDICAL SCIENCE、WENZHOU MEDICAL UNIVERSITY、CAPITAL MEDICAL UNIVERSITY等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
2区
IMMUNOLOGY 免疫学
3区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
IMMUNOLOGY 免疫学
3区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
IMMUNOLOGY 免疫学
3区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:IMMUNOLOGY SCIE Q1 40 / 183

78.4

学科:IMMUNOLOGY SCIE Q2 55 / 183

70.22

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:IMMUNOLOGY SCIE Q2 63 / 183

65.8

学科:IMMUNOLOGY SCIE Q2 61 / 183

66.94


中国学者近期发文

1
TCF4 contributes to OA progression by regulating the transcription of LOXL

Author:Wang, Jiquan; Liu, Xiaojun; Fan, Xinyi; Zhang, Yiming; Ouyang, Haiyang

Journal: JOURNAL OF INFLAMMATION-LONDON. 2026; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12950-026-00494-w

2
Resolvin D1 alleviates liver inflammation and fibrosis through SIRT1-mediated NF-κB and TGF-β1/Smads pathway

Author:Li, Jiahuan; Zhao, Lingfeng; Xi, Yuwen; Deng, Xiaoling

Journal: JOURNAL OF INFLAMMATION-LONDON. 2026; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12950-026-00492-y

3
Quercetin-loaded silicon dioxide-graphene nanoparticles promotes M2 macrophage reprogramming in mycoplasma-induced pneumoni

Author:Liu, Xiuxiu; Chen, Xiufeng; Jiang, Yonghong; Li, Wen; Fei, Xiaoqin; Li, Xiao; Jiang, Zhiyan

Journal: JOURNAL OF INFLAMMATION-LONDON. 2026; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12950-026-00484-y

4
Diagnostic and prognostic value of LINC00278 in patients with severe pneumonia and its regulatory rol

Author:Liu, Yanshan; Zhou, Cuihong; Guo, Zhipeng; Liu, Xiaofen

Journal: JOURNAL OF INFLAMMATION-LONDON. 2026; Vol. 23, Issue 1, pp. -. DOI: 10.1186/s12950-026-00486-w

5
The soluble epoxide hydrolase inhibitor TPPU alleviates Aβ-mediated neuroinflammatory responses in Drosophila melanogaster and cellular models of alzheimer's diseas

Author:Sun, Xiaowen; Liu, Hongxiang; Li, Wei; Li, Lin; Tian, Qian; Cao, Qingyang; Meng, Yun; Shen, Yan; Che, Fengyuan; Chiu, Joanna C.; Yu, Jixu; Hammock, Bruce D

Journal: JOURNAL OF INFLAMMATION-LONDON. 2025; Vol. 22, Issue 1, pp. -. DOI: 10.1186/s12950-025-00449-7

6
Mesenchymal stem cell-derived exosomal CBLB ameliorates infantile pneumonia progression probably by ubiquitinating MAPK1

Author:Guo, Fang; Song, Fuxing; Chen, Zhenjiang; Niu, Na; Sun, Lina; Yan, Min; Liu, Min

Journal: JOURNAL OF INFLAMMATION-LONDON. 2025; Vol. 22, Issue 1, pp. -. DOI: 10.1186/s12950-025-00450-0

7
RhIL-11 reverses liver damage in septic mice by STAT3-mediated M-MDSCs induction modulated by a parallel mTORC1 signaling branc

Author:Liu, Yuefang; Gao, Shujun; Li, Zhanghui; Yin, Lei; Ge, Shiyao; Zhao, Yangjing; Wang, Hui; Wan, Bing; Shao, Qixiang

Journal: JOURNAL OF INFLAMMATION-LONDON. 2025; Vol. 22, Issue 1, pp. -. DOI: 10.1186/s12950-025-00447-9

8
Exosomes derived from M2 macrophages regulate airway inflammation by modulating epithelial cell proliferation and apoptosi

Author:Ren, Yinying; Zhou, Mi; Li, Yuehan; Li, Yan; Xiang, Jinying; Deng, Fang; Luo, Zhengxiu; Liu, Enmei; Yu, Jinyue; Fu, Zhou; Ding, Fengxia; Liu, Bo

Journal: JOURNAL OF INFLAMMATION-LONDON. 2025; Vol. 22, Issue 1, pp. -. DOI: 10.1186/s12950-025-00444-y

9
Mucosal immunotherapy targeting APC in lung diseas

Author:Liu, Yangqi; Chen, Zijian; Cheng, Hanchang; Zheng, Runzhi; Huang, Weizhe

Journal: JOURNAL OF INFLAMMATION-LONDON. 2025; Vol. 22, Issue 1, pp. -. DOI: 10.1186/s12950-025-00432-2

10
Exploring the mitigating potential of anthocyanin Malvidin in a mouse model of bleomycin-induced pulmonary fibrosis by inhibiting NLRP3 inflammasome activation and oxidative stres

Author:Zhou, Dingzi; Cai, Lin; Xu, Jie; Fu, Daigang; Yan, Ling; Xie, Linshen

Journal: JOURNAL OF INFLAMMATION-LONDON. 2025; Vol. 22, Issue 1, pp. -. DOI: 10.1186/s12950-025-00441-1


在线咨询

Journal Of Inflammation-london

国际简称:J INFLAMM-LOND参考译名:炎症杂志-伦敦

年发文量:52 CiteScore:6.8 是否预警:否 Gold OA文章占比:100.00% 研究类文章占比:82.69%

杂志社联系方式:BIOMED CENTRAL LTD, 236 GRAYS INN RD, FLOOR 6, LONDON, ENGLAND, WC1X 8HL

Journal Of Inflammation-london